Renowned scientific publisher “nature“ brings pathbreaking results on novel nano3DSense-sensors in September issue of “nature communications” journal. Thanks to nano3DSense nanoprinting technology the smallest known and commercially available sensors for force and pressure measuring are provided that are now surpassing in terms of compactness, sensing speed and sensitivity ...

New biosensors enable fast and label-free immunoassays and detection of biomolecules, such as antibodies and proteins, with previously unimagined precision. And this cost-efficiently and in multi-functional use, e.g. in point of care (POC) diagnosis of disease biomarkers (Diabetes, Cancer, Acute Myocardial Infarction (AMI)), pathogens (viruses, bacteria, MRSA, VRE) and molecular analysis (DNA, RNA-sequencing, oligonucleotides and aptamers) without the need for PCR (polymerase chain reaction).

Force and pressure sensors and their application in medical technology for diagnostic implants and catheters were fundamentally redefined. We guarantee highest possible minimally invasive feature sizes for sensor implants and other invasive devices in surgery that provide outstanding long-term reliability and biocompatibility. Whether for precise intracardiac blood pressure measurement (e.g. during therapy of hypertension and heart failure), implants for diabetes CGM (continuous glucose monitoring) or ultra-small 3D force sensors for catheters: Implementing innovative ideas has never been easier.